Peptide-displaying Phage Technology In Breast Cancer Diagnosis | 24123
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Phage display is a molecular technique by which foreign proteins are expressed at the surface of phage particles. This is an
extremely powerful tool for selecting peptides with specific binding properties from vast numbers of variants. Considering
tumors, is a promise technology in selecting targets with clinical relevance, able in recognize molecular diversity of cancer.
It has been characterized by phage display a new FabC4 antibody with clinical relevance in diagnostics, disease staging, and
prognosis. However, further characterization of its target is essential for BC management. In this study, a biopanning assay
against FabC4 using PH.D-12 library was performed. To isolate peptides that recognize our FabC4 antibody, a subtractive
selection procedure was applied against an irrelevant Fab, and the elution of ligands was performed in two steps: with nonmalignant
proteins, which were discarded, and with BC proteins, which were amplified. It was shown, by Phage-ELISA, that six
clones differentiated sera samples from 50 patients with BC, benign disease, and from health women. Chemically synthesized
peptides were specifically direct against FabC4, and tested against 150 patients. Absorbance for sera from patients with BC
was significantly higher than samples from benign disease and health women. Obtained results open new perspectives in BC
diagnostic, target therapy and demonstrate the selective of the applied procedure. The use of synthetic peptides proved to be
an excellent assay that was reproducible, simple, fast, and inexpensive, and it can be applied in diagnostic and therapeutic
Thaise Gon?alves Araujo has completed her PhD at Federal University of Uberlandia, Brazil in 2012, working with breast cancer and phage display technology.
She collaborated with NIH developing projects with phage display and HIV antibodies. She has published papers incancer areas and is professor of the Federal
University of Uberlandia.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals